Capecitabine Tablets, Usp 150 mg (NDC 82511-001-15)
Capecitabine Tablet, Film Coated
Product Images NDC 82511-002
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Capecitabine (NDC 82511-002). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Teyro Labs Private Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Capecitabine Tablets, Usp 150 mg (NDC 82511-001-15)
Capecitabine Tablets, Usp 500 mg (NDC 82511-002-50)
This text appears to be the packaging or label information for a medication called Capecitabine. Capecitabine is a hazardous drug that comes in the form of film-coated tablets. The recommended dosage and instructions for patients are not provided in this text. It should be swallowed whole with water within 30 minutes of a meal and should not be crushed or cut. The medication should be stored in tightly closed, tight containers at a temperature range of 15°C to 30°C (50°F to 86°F). The manufacturer of this medication is Teyro Labs Private Limited, located in Tamil Nadu, India.*
Capecitabine Tablets, Usp 500 mg (NDC 82511-002-50)
Each Film-coated tablet contains 500 mg of Capecitabine, USP. It is manufactured by Teyro Labs Privale Limited. The recommended dosage and prescribing information should be consulted. The tablets should be swallowed whole and not crushed. The NDC code for the tablets is 82511-002-50. The tablets should be stored at 20°C to 25°C (68°F to 77°F), with permitted excursions from 15°C to 30°C (59°F to 86°F) as stated in USP. Dispensing should be done in tight containers according to USP/N standards. The package contains 120 tablets measuring 42x18 mm. The manufacturing revision date is 052023. The text is not available for evaluation.*
Figure 1 (Capecitabine Tablets Usp Figure 1)
Figure 2 (Capecitabine Tablets Usp Figure 2)
Figure 3 (Capecitabine Tablets Usp Figure 3)
Figure 4 (Capecitabine Tablets Usp Figure 4)
Figure 5 (Capecitabine Tablets Usp Figure 5)
Chemical Structure (Capecitabine Tablets Usp Structure)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
